Stockreport

Neoleukin Therapeutics Provides Update on COVID-19 Impact on Corporate and Clinical Development Activities [Canadian Business Journal (Canada)]

Neoleukin Therapeutics, Inc.  (NLTX) 
PDF SEATTLE, April 09, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc. “Neoleukin” (NASDAQ:NLTXde novo“During this unprecedented time, protecting the health and well-be [Read more]